Perrigo | PRGO - Selling And Administration Expenses


Perrigo reported $3.28B in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
AbbVie USD 3.63B 54M Jun/2026
Abbott USD 4.27B 669M Sep/2026
Bayer EUR 3.96B 267M Jun/2026
Bristol-Myers Squibb USD 1.83B 209M Jun/2026
Coherus Biosciences USD 15M 6.26M Dec/2025
Corcept Therapeutics USD 156.9M 28.85M Jun/2026
Dr.Reddys Laboratories INR 26.1B 11.63B Jun/2026
Eli Lilly USD 3.43B 496M Jun/2026
J&J USD 6.25B 168M Sep/2026
Merck USD 2.89B 219M Jun/2026
Nestle CHF 12.33B 133M Jun/2026
Pacira USD 91.81M 7.93M Jun/2026
Perrigo USD 3.28B 3.02B Jun/2026
Pfizer USD 3.41B 496M Jun/2026
Phibro Animal Health USD 78.32M 10.24M Dec/2025
Prestige Brands USD 43.3M 13.02M Jun/2026
Sanofi EUR 2.63B 307M Jun/2026
Supernus Pharmaceuticals USD 133.64M 15.41M Jun/2026
Teva Pharmaceutical Industries USD 1.03B 34M Jun/2026
Xeris Pharmaceuticals USD 53.14M 10.51M Mar/2026
Zoetis USD 592M 4M Jun/2026